Cost‐effectiveness of omalizumab for the treatment of chronic spontaneous urticaria von Kanters, T.A., Thio, H.B., Hakkaart, L.

Volltext

Budget Impact of Orphan Drugs In the Netherlands In The Period 2006-2012 von Kanters, T.A, Steenhoek, A, Hakkaart, L

Volltext

Multi-Criteria Decision Analysis for Reimbursing Orphan Drugs: A Dutch Demonstration Study Using the Analytic Hierarchy Process Method von Trip, A.M, Tsiachristas, A, Koenders, J.M, Kanters, T.A

Volltext

Cost-Effectiveness of Enzyme Replacement Therapy (ERT) with Alglucosidase Alfa in Classic-Infantile Patients with Pompe Disease von Kanters, T.A, Plug, I, Rutten-van Mölken, M.P.M.H, Redekop, W, Van der Ploeg, A.T, Hakkaart, L

Volltext

奥马珠单抗治疗自发慢性荨麻疹的成本效益 von Kanters, T.A., Thio, H.B., Hakkaart, L.

Volltext

WITHDRAWN: Erratum to “Cost-effectiveness of omalizumab in chronic spontaneous urticaria” von Kanters, T.A., Gertsen, K., Hakkaart, L.

Volltext

Cost‐effectiveness of omalizumab in chronic spontaneous urticaria von Kanters, T.A., Thio, H.B., Hakkaart, L.

Volltext

PCN330 A COMPARISON OF HEALTHCARE AND SOCIETAL COSTS OF HOSPITAL-BASED AND HOME-BASED SUBCUTANEOUS INJECTIONS OF TRASTUZUMAB von Franken, M.G., Kanters, T.A., Coenen, J.L., Jong, P., Jager, A., Uyl-de Groot, C.A.

Volltext

PSY24 - Budget Impact of Orphan Drugs In the Netherlands In The Period 2006-2012 von Kanters, T.A., Steenhoek, A., Hakkaart, L.

Volltext

PCN85 - SAVING HEALTHCARE AND SOCIETAL COSTS BY CHANGING THE ROUTE OF ADMINISTRATION OF ONCOLOGY DRUGS von Franken, M.G., Kanters, T.A., Coenen, J.L., de Jong, P., Koene, H.R., Lugtenburg, P.J., Jager, A., Uyl-de Groot, C.A.

Volltext

PSY114 - Multi-Criteria Decision Analysis for Reimbursing Orphan Drugs: A Dutch Demonstration Study Using the Analytic Hierarchy Process Method von Trip, A.M., Tsiachristas, A., Koenders, J.M., Kanters, T.A.

Volltext

奥马珠单抗治疗自发慢性荨麻疹的成本效益 von Kanters, T.A., Thio, H.B., Hakkaart, L.

Volltext

PSY37 - Cost-Effectiveness of Enzyme Replacement Therapy (ERT) with Alglucosidase Alfa in Classic-Infantile Patients with Pompe Disease von Kanters, T.A., Plug, I., Rutten-van Mölken, M.P.M.H., Redekop, W., Van der Ploeg, A.T., Hakkaart, L.

Volltext

Quality of Life and Participation in the Daily Life (Activities) of Adults with Pompe Disease Receiving Enzyme Replacement Therapy: 10 Years of International Follow-Up von Güngör, D., Kruijshaar, M.E., Plug, I., Rizopoulos, D., Kanters, T.A., Wens, S.C.A, Reuser, A.J.J, van Doorn, P.A., van der Ploeg, A.T.

Volltext